The more recently developed tirzepatide is a member of the class known as “twincretins,” with GIP RA activity potentiating the effects of the GLP RA and resulting in comparable, if not better, control of diabetes and weight.29-33. This evidence concerns the gene GIP and diabetes mellitus.